Ipamorelin 5 No Label

 Ipamorelin Packing: 1 vial - 5mg.

What is Ipamorelin?
Ipamorelin is a synthetic pentapeptide classified as a growth hormone secretagogue (GHS). It belongs to the class of Growth Hormone Releasing Peptides (GHRPs) and is designed to mimic the action of ghrelin, the natural hunger hormone that stimulates GH release. This 5 mg product is provided as a highly pure, unlabeled lyophilized powder for controlled laboratory research.

What does it do?
Ipamorelin works by selectively binding to the ghrelin receptor (GHS-R1a) in the pituitary gland and hypothalamus. This action potently stimulates the natural, pulsatile secretion of endogenous growth hormone (GH). It is noted for its selectivity, as it has minimal to no significant effect on the release of other hormones like cortisol, prolactin, or ACTH, unlike some earlier GHRPs.

How is it used?
This material is supplied exclusively for in-vitro and laboratory research applications. Prior to use, it must be reconstituted with a sterile solvent such as bacteriostatic water. Subsequent handling, dilution, and application must be performed according to established research protocols under controlled laboratory conditions. All safety and ethical guidelines for research chemicals must be strictly followed.

Potential Benefits (in a research context):

• Potent & Selective GH Release: Stimulates a significant increase in growth hormone levels, crucial for studies on metabolism, tissue growth, and repair.

• Improved Body Composition: Research indicates a role in supporting lean muscle mass accretion and promoting lipolysis (fat breakdown) through increased GH.

• Enhanced Recovery & Sleep: May support tissue repair mechanisms and improve sleep quality, as GH secretion is tied to restorative sleep cycles.

• Bone Density & Cartilage Health: Useful in studies investigating the anabolic effects of GH on bone and connective tissues.

• Cleaner Hormonal Profile: Its selectivity makes it a valuable compound for studies requiring isolated GH response without confounding effects from cortisol or prolactin.

Possible Side Effects (research observations):
In experimental models, the following reactions have been associated with GHRP administration:

• Transient flushing or warmth in the face

• Mild, temporary headache or lightheadedness

• Hunger pangs or increased appetite shortly after administration

• Occasional tingling sensations in the extremities

• Local irritation at the site of injection in subcutaneous models

• Theoretical risk of fluid retention or carpal tunnel symptoms with prolonged, supra-physiological dosing.